Jeffrey W. Sherman, M.D., FACP

Jeffrey W. Sherman, M.D., FACP

DirectoratLarimar Therapeutics· In proxies 2023–2025

Jeffrey W. Sherman, M.D., FACP sits on 1 public board.

Experience

  1. Larimar TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role -36%
  2. Xeris Biopharma Holdings, Inc.Public company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?